Skipping steps to biopharma 4.0

被引：0

|

作者：

Shanley, Agnes

机构：

来源：

Pharmaceutical Technology | 2020年 / 44卷 / 08期

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

3

引用

收藏

页码：37 / 38

相关论文

共 50 条

[21] Biopharma Taps Bioprocessing 4.0 Benefits Start Flowing Experts from Cytiva, Lonza, and Pfizer describe how biopharma is embracing data-driven and software-defined bioprocessing systems
Macdonald G.J.
Genetic Engineering and Biotechnology News, 2023, 43 (10): : 54 - 56and58
[22] Booming biopharma
Eisberg, Neil
CHEMISTRY & INDUSTRY, 2021, 85 (04) : 4 - 4
[23] Principia Biopharma
Garber, Ken
NATURE BIOTECHNOLOGY, 2013, 31 (05) : 377 - 377
[24] Biopharma buyouts
不详
TCE, 2010, (829-30): : 10 - 10
[25] The next move in biopharma
Dorey, Emma
CHEMISTRY & INDUSTRY, 2010, (24) : 14 - 15
[26] Biopharma dealmaking in 2019
Micklus, Amanda
Giglio, Patricia
NATURE REVIEWS DRUG DISCOVERY, 2020, 19 (02) : 87 - 88
[27] Biopharma dealmaking in 2023
Giglio, Patricia
Micklus, Amanda
NATURE REVIEWS DRUG DISCOVERY, 2024, 23 (02) : 101 - 102
[28] Biopharma eyes outsourcing
McCoy, M
CHEMICAL & ENGINEERING NEWS, 1998, 76 (30) : 27 - 32
[29] ARRAY BIOPHARMA TO RESTRUCTURE
不详
CHEMICAL & ENGINEERING NEWS, 2011, 89 (25) : 22 - 22
[30] The Biopharma Working Life
Peters, Rita
BIOPHARM INTERNATIONAL, 2014, 27 (12) : 6 - 6

← 1 2 3 4 5 →